BioCentury | Jan 7, 2016
Financial News

Financial tracks

...Aisling Capital hired Eric Aguiar as partner. He was a partner at Thomas, McNerney & Partners. BC Staff...
BioCentury | Oct 20, 2014
Financial News

Invitae completes venture financing

Invitae Corp. , San Francisco, Calif. Business: Diagnostic Date completed: 2014-10-13 Type: Venture financing Raised: $120 million Placement agent: JPMorgan Investors: Decheng Capital; Deerfield Management; OrbiMed Advisors; Perceptive Advisors; Rock Springs Capital; Wellington Management; Casdin Capital...
BioCentury | Oct 14, 2014
Financial News

Invitae raises $120M in F round

Invitae Corp. (San Francisco, Calif.) raised $120 million in a series F round to build out its one-stop genetic testing service. The company aims to aggregate a complete catalog of genetic diagnostic tests and offer...
BioCentury | Jan 13, 2014
Financial News

Auspex completes venture financing

Auspex Pharmaceuticals Inc. , La Jolla, Calif. Business: Chemistry, Neurology Date completed: 1/8/14 Type: Venture financing Raised: $20 million Investors: Deerfield Management; Thomas McNerney & Partners; CMEA Capital; Panorama Capital; BioMed Venture; Costa Verde Capital WIR...
BioCentury | Jan 9, 2014
Financial News

Rare neurology disease play Auspex raises $35M

...$20 million in a series E round led by new investor Deerfield Management. Existing investors Thomas, McNerney...
BioCentury | Dec 16, 2013
Financial News

Invitae completes venture financing

Invitae Corp. , San Francisco, Calif. Business: Diagnostic Date completed: 12/10/13 Type: Venture financing Raised: $40 million Investors: Genomic Health Inc. ; Thomas McNerney & Partners; Redmile Group; Genesys Capital Partners; Casdin Capital; company management; existing...
BioCentury | Dec 11, 2013
Financial News

Invitae raises $40 million E round

Genetic diagnostics company Invitae Corp. (San Francisco, Calif.) raised $40 million in a series E round. Investors in the round include cancer diagnostic company Genomic Health Inc. (NASDAQ:GHDX) and Invitae co-founder, Chairman and CEO Randy...
BioCentury | Jul 22, 2013
Financial News

Ocera completes private placement

...Private placement Raised: $20 million Price: $6.03 Shares after offering: 11.3 million Investors: Domain Associates; Thomas, McNerney...
BioCentury | Apr 29, 2013
Finance

Plenty supply; shrinking demand

Despite a gloomy quarterly report from PricewaterhouseCoopers and the National Venture Capital Association that noted a dearth in first-time financings for drug and device newcos in the U.S., at least one investor sees reason for...
BioCentury | Nov 12, 2012
Financial News

Auspex completes venture financing

...Business: Chemistry, Neurology Date completed: 11/8/12 Type: Venture financing Raised: $25 million Investors: Panorama Capital; Thomas, McNerney...
Items per page:
1 - 10 of 84
BioCentury | Jan 7, 2016
Financial News

Financial tracks

...Aisling Capital hired Eric Aguiar as partner. He was a partner at Thomas, McNerney & Partners. BC Staff...
BioCentury | Oct 20, 2014
Financial News

Invitae completes venture financing

Invitae Corp. , San Francisco, Calif. Business: Diagnostic Date completed: 2014-10-13 Type: Venture financing Raised: $120 million Placement agent: JPMorgan Investors: Decheng Capital; Deerfield Management; OrbiMed Advisors; Perceptive Advisors; Rock Springs Capital; Wellington Management; Casdin Capital...
BioCentury | Oct 14, 2014
Financial News

Invitae raises $120M in F round

Invitae Corp. (San Francisco, Calif.) raised $120 million in a series F round to build out its one-stop genetic testing service. The company aims to aggregate a complete catalog of genetic diagnostic tests and offer...
BioCentury | Jan 13, 2014
Financial News

Auspex completes venture financing

Auspex Pharmaceuticals Inc. , La Jolla, Calif. Business: Chemistry, Neurology Date completed: 1/8/14 Type: Venture financing Raised: $20 million Investors: Deerfield Management; Thomas McNerney & Partners; CMEA Capital; Panorama Capital; BioMed Venture; Costa Verde Capital WIR...
BioCentury | Jan 9, 2014
Financial News

Rare neurology disease play Auspex raises $35M

...$20 million in a series E round led by new investor Deerfield Management. Existing investors Thomas, McNerney...
BioCentury | Dec 16, 2013
Financial News

Invitae completes venture financing

Invitae Corp. , San Francisco, Calif. Business: Diagnostic Date completed: 12/10/13 Type: Venture financing Raised: $40 million Investors: Genomic Health Inc. ; Thomas McNerney & Partners; Redmile Group; Genesys Capital Partners; Casdin Capital; company management; existing...
BioCentury | Dec 11, 2013
Financial News

Invitae raises $40 million E round

Genetic diagnostics company Invitae Corp. (San Francisco, Calif.) raised $40 million in a series E round. Investors in the round include cancer diagnostic company Genomic Health Inc. (NASDAQ:GHDX) and Invitae co-founder, Chairman and CEO Randy...
BioCentury | Jul 22, 2013
Financial News

Ocera completes private placement

...Private placement Raised: $20 million Price: $6.03 Shares after offering: 11.3 million Investors: Domain Associates; Thomas, McNerney...
BioCentury | Apr 29, 2013
Finance

Plenty supply; shrinking demand

Despite a gloomy quarterly report from PricewaterhouseCoopers and the National Venture Capital Association that noted a dearth in first-time financings for drug and device newcos in the U.S., at least one investor sees reason for...
BioCentury | Nov 12, 2012
Financial News

Auspex completes venture financing

...Business: Chemistry, Neurology Date completed: 11/8/12 Type: Venture financing Raised: $25 million Investors: Panorama Capital; Thomas, McNerney...
Items per page:
1 - 10 of 84